期刊文献+

罗匹尼罗中间体4-(2-苯甲酰氧乙基)-3-氯-1,3-二氢-2H-吲哚啉-2-酮的合成 被引量:1

Synthesis of 4-[2-(benzoyloxy)ethyl]-3-chloro-1,3-dihydro-2H-indolin-2-one,an Intermidiate of Ropinirole
下载PDF
导出
摘要 以苯乙醇为原料,经分子内Friedel-Crafts烷基化反应合成了异色满,接着开环、成盐、水解得到苯甲酸-2-甲酰基苯乙基酯,再和硝基甲烷反应制备2-[2-(苯甲酰氧基)乙基]-β-硝基苯乙烯,最后通过Royer反应环合生成罗匹尼罗中间体4-(2-苯甲酰氧乙基)-3-氯-1,3-二氢-2H-吲哚啉-2-酮。产品经由薄层色谱、核磁共振谱、红外光谱分析,确为目的化合物,总收率为31.51%。 Isoehroman was synthesized from phenyl ethanol by inner molecular Friedel-Crafts alkylation reaction. The intermidiate of Ropinirole 4-[ 2-(benzoyloxy) ethyl ]-3-ehloro-1,3-dihydro-2H-indolin-2-one was prepared from isochroman by ring opening, salt formation, hydrolysis, nitrostyrene formation and Royer reaction. The target product was confirmed by the analysis of TLC,^1 H-NMR,IR.The total yield is 31.51%.
出处 《化学工业与工程》 CAS 2006年第1期29-32,共4页 Chemical Industry and Engineering
关键词 罗匹尼罗 帕金森症 多巴胺D2受体激动剂 合成 Ropinirole Parkinson disease dopamine D2 receptor agonist synthesis
  • 相关文献

参考文献9

二级参考文献34

  • 1沈建英.帕金森病药物可延缓疾病进程[J].国外药讯,2002,8:13-13.
  • 2崔银珠.多巴胺激动剂盐酸罗匹尼罗是治疗帕森病的一线药物[J].国外医药—合成药、生化药、制药分册,2000,21(2):119-119.
  • 3钟倩.罗匹尼罗获FDA许可[J].国外医药—合成药、生化药、制剂分册,1998,19(2):120-120.
  • 4胡润生.治疗帕金森氏病的新药ropinirole首次上市[J].国外药讯,1997,2:21-21.
  • 5Reichmann H, Lachenmayer L. 1st long-term double-blind study of effectiress and dyskinesia Prerention of ropinirole. Nervenarzt, 2000; 71(12):1012~1014.
  • 6Kuzel MD. Ropinirole; a dopamine agonist for the freatment of Parkinson's dimase. Am J Health-Systpharm, 1999 ; 56 (3) : 217 ~ 224.
  • 7Koller WC, Hubblel JP. Levodopa therapy in Parkinson's disease. Neurol, 1990; 40 (Suppl3) :40-44.
  • 8Corona-Morales AA, Castell A, Zhang L. LDoPA-induced neurotoxic and apoptotic changes on cultured chromaffin Cells. Neuroreport, 2000;11(3) :503.
  • 9Jones DC, Gunasekar PG, Borowitz JL, et al.Dopamine-induced apoptosis is mediated by oxidative stress and is enhanced by cyanide in differentiated PC12 cells. J Neurochem. 2000:74(6):2296.
  • 10Rascol O. ,Brooks D J Korczyn A D et al.A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa. N Engl J Med ,2000;342(20):1484~1491.

共引文献14

同被引文献15

  • 1王晓钟,戴立言,陈英奇,王军明.醋丁洛尔的合成新工艺研究[J].高校化学工程学报,2004,18(6):729-732. 被引量:5
  • 2Gallagher G Jr,Lavanchy P G,Webster C A,et al.4-[2-(Di-n-propylamino) ethyl]-2(3H)-indolone:a prejunctional dopamine receptor agonist[J].J Med Chem,1985,28(10):1533-1536.
  • 3Gregory G Jr.4-Aminoalkyl-2(3H)-indolones:USP,4452808[P].1982-12-07.
  • 4Fortunak J M,Giles R G,Walsgrove T C.Process for preparing substituted isoindolinone derivatives:EP,0300614[P].1988-06-16.
  • 5Hayer J D,Howie S L B,Giles R G,et al.Some synthetic approaches to ropinirole(SK&F101468-A):A potent dopamine receptor agonist[J].J Heterocyclic Chem,1995,32:875.
  • 6Smithkline & French Laboratories Limited,An improved process for the preparation of substituted indolone derivatives:WO,91/16306[P].1991-02-05.
  • 7Hayer J D,Howie S L B,Giles R G,et al.Development of large-scale synthesis of ropinirole in the pursuit of a manufacturing process[J].Organic Process research & Development,1998,2(1):3-9.
  • 8Liu Mei-zheng (刘美正).Novel process for Ropinirle preparation:US,2009043111[P],2007-08-06.
  • 9LIU Mei-zheng(刘美正),PAN Jian-lin(潘建林).A process for the preparation of Ropinirole and its derivatives(罗匹尼罗及其衍生物的制备方法):CN,1974553[P].2006-08-14.
  • 10Beech W F.2-Methyl-5-nitrobenzaldehyde[J].Journal of the Chemical Society[section C]:Organic,1967,22:2314-2315.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部